SG11201908629WA - Anti-inflammatory agent - Google Patents
Anti-inflammatory agentInfo
- Publication number
- SG11201908629WA SG11201908629WA SG11201908629WA SG11201908629WA SG 11201908629W A SG11201908629W A SG 11201908629WA SG 11201908629W A SG11201908629W A SG 11201908629WA SG 11201908629W A SG11201908629W A SG 11201908629WA
- Authority
- SG
- Singapore
- Prior art keywords
- inflammatory agent
- composition
- pop
- present
- olanexidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017082793 | 2017-04-19 | ||
| PCT/JP2018/014999 WO2018193904A1 (ja) | 2017-04-19 | 2018-04-10 | 抗炎症剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201908629WA true SG11201908629WA (en) | 2019-10-30 |
Family
ID=63855845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201908629W SG11201908629WA (en) | 2017-04-19 | 2018-04-10 | Anti-inflammatory agent |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11229615B2 (ja) |
| EP (1) | EP3628314B1 (ja) |
| JP (1) | JP6802365B2 (ja) |
| KR (1) | KR102253831B1 (ja) |
| CN (1) | CN110494132A (ja) |
| AU (1) | AU2018256060B2 (ja) |
| CA (1) | CA3058592C (ja) |
| ES (1) | ES2956040T3 (ja) |
| PH (1) | PH12019550207A1 (ja) |
| RU (1) | RU2738845C1 (ja) |
| SG (1) | SG11201908629WA (ja) |
| TW (1) | TWI675658B (ja) |
| WO (1) | WO2018193904A1 (ja) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2064664C (en) | 1991-04-05 | 2000-01-11 | Hiroshi Ishikawa | Biguanide derivatives, manufacturing method thereof, and disinfectants containing the derivatives |
| US20020013331A1 (en) | 2000-06-26 | 2002-01-31 | Williams Robert O. | Methods and compositions for treating pain of the mucous membrane |
| WO2002041837A2 (en) * | 2000-11-22 | 2002-05-30 | Rxkinetix, Inc. | Treatment of mucositis |
| JP4526300B2 (ja) * | 2003-05-28 | 2010-08-18 | 大塚製薬株式会社 | オラネキシジン水溶液およびその調製方法並びに消毒剤 |
| JP4541661B2 (ja) * | 2003-05-28 | 2010-09-08 | 大塚製薬株式会社 | 消毒および／または殺菌用組成物 |
| JP4580153B2 (ja) * | 2003-06-30 | 2010-11-10 | 大塚製薬株式会社 | 消毒および／または殺菌用組成物 |
| TW200509893A (en) | 2003-05-28 | 2005-03-16 | Otsuka Pharma Co Ltd | A composition for sterilizing and/ or disinfecting |
| MXPA05012761A (es) | 2003-05-28 | 2006-05-17 | Otsuka Pharma Co Ltd | Solucion acuosa de olanexidina, metodo para preparar la solucion acuosa y desinfectante. |
| JP2005343964A (ja) * | 2004-06-01 | 2005-12-15 | Otsuka Pharmaceut Factory Inc | ポリアルキレングリコール類含有水溶液、及びその調製方法 |
| EP1827562A2 (en) * | 2004-11-17 | 2007-09-05 | Otsuka America Pharmaceutical, Inc. | Fluid application device and method |
| AU2006244080C1 (en) * | 2005-05-10 | 2012-02-02 | The University Of Chicago | Use of peptides derived from the growth factor AMP-18 for the treatment of mucositis |
| KR101334413B1 (ko) | 2006-02-14 | 2013-11-29 | 엔투리아, 인코포레이티드 | 방부제로부터 부산물의 농도를 감소시키기 위한 액체 도포기 및 방법 |
| TWI556845B (zh) * | 2008-12-30 | 2016-11-11 | 大塚美國製藥股份有限公司 | 施加流體的裝置和方法 |
| ES2885449T3 (es) * | 2013-02-07 | 2021-12-13 | Ingalfarma Spa | Composición antiséptica oral para el tratamiento de mucositis oral |
| US20150231095A1 (en) * | 2013-04-18 | 2015-08-20 | Steven A. Melman | Antimicrobial compositions and uses therefore |
| NO342617B1 (no) * | 2014-06-18 | 2018-06-18 | Meda Otc Ab | Oral formulering omfattende et antibakterielt middel for å forebygge og/eller behandle halitose, dårlig ånde, munntørrhet eller sår hals |
| JP6602639B2 (ja) * | 2015-10-21 | 2019-11-06 | 株式会社大塚製薬工場 | がんの治療による口腔粘膜炎の改善・予防用組成物 |
-
2018
- 2018-04-10 ES ES18787649T patent/ES2956040T3/es active Active
- 2018-04-10 CA CA3058592A patent/CA3058592C/en active Active
- 2018-04-10 AU AU2018256060A patent/AU2018256060B2/en active Active
- 2018-04-10 US US16/605,363 patent/US11229615B2/en active Active
- 2018-04-10 SG SG11201908629W patent/SG11201908629WA/en unknown
- 2018-04-10 KR KR1020197029589A patent/KR102253831B1/ko active IP Right Grant
- 2018-04-10 EP EP18787649.5A patent/EP3628314B1/en active Active
- 2018-04-10 RU RU2019132614A patent/RU2738845C1/ru active
- 2018-04-10 CN CN201880024116.5A patent/CN110494132A/zh active Pending
- 2018-04-10 JP JP2019513564A patent/JP6802365B2/ja active Active
- 2018-04-10 WO PCT/JP2018/014999 patent/WO2018193904A1/ja unknown
- 2018-04-11 TW TW107112457A patent/TWI675658B/zh active
-
2019
- 2019-10-02 PH PH12019550207A patent/PH12019550207A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US11229615B2 (en) | 2022-01-25 |
| KR102253831B1 (ko) | 2021-05-20 |
| CA3058592C (en) | 2021-11-09 |
| CN110494132A (zh) | 2019-11-22 |
| TWI675658B (zh) | 2019-11-01 |
| TW201841631A (zh) | 2018-12-01 |
| WO2018193904A1 (ja) | 2018-10-25 |
| KR20190123780A (ko) | 2019-11-01 |
| CA3058592A1 (en) | 2018-10-25 |
| ES2956040T3 (es) | 2023-12-12 |
| RU2738845C1 (ru) | 2020-12-17 |
| EP3628314A4 (en) | 2020-10-28 |
| AU2018256060A1 (en) | 2019-10-17 |
| AU2018256060B2 (en) | 2020-08-06 |
| JPWO2018193904A1 (ja) | 2020-01-09 |
| PH12019550207A1 (en) | 2020-09-21 |
| US20210121417A1 (en) | 2021-04-29 |
| EP3628314B1 (en) | 2023-07-26 |
| JP6802365B2 (ja) | 2020-12-16 |
| EP3628314A1 (en) | 2020-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022000711A (es) | Inhibidores de parp1. | |
| WO2014186742A3 (en) | Anhydrous hydrogel composition | |
| MX2019007187A (es) | Composiciones para el cuidado bucal. | |
| MX2021000093A (es) | Antagonistas del receptor de tipo toll 7/8 (tlr7/8) y usos de los mismos. | |
| EP4248968A3 (en) | Tlr7/8 antagonists and uses thereof | |
| MY195190A (en) | Controlled-Release Cnp Agonists With Increased Nep Stability | |
| CY1126067T1 (el) | Συντηγμενες πυρρολινες που δρουν σαν ειδικοι για ουβικιτινη αναστολεις πρωτεασης 30 (usp30) | |
| MX2023013577A (es) | Composiciones de bismuto-tiol y metodos de uso. | |
| GEP20247585B (en) | Furoindazole derivatives | |
| CA3156259A1 (en) | METHODS OF USING ORAL CARE COMPOSITIONS COMPRISING HOPS | |
| ZA202201364B (en) | Deuterated compounds for use in the treatment of cancer | |
| ZA202006377B (en) | Boronic acid derivatives and therapeutic uses thereof | |
| EA202192867A1 (ru) | Составы с пролонгированным высвобождением | |
| WO2021046315A3 (en) | Inhibitors of encephalitic alphaviruses | |
| JOP20190156B1 (ar) | أميدات عطرية لحمض الكربوكسيليك بصفتها مضادات لمستقبلة البراديكينين b1 | |
| MX2019007361A (es) | Composiciones para el cuidado bucal. | |
| SG11201908629WA (en) | Anti-inflammatory agent | |
| NZ757526A (en) | Naphthoquinones, their derivatives and uses thereof in methods for the treatment of mitochondrial dysfunction | |
| MX2020001199A (es) | Compuestos y composiciones farmaceuticas de los mismos para usarse en el tratamiento de enfermedades fibroticas. | |
| UA117200C2 (uk) | Водні фармацевтичні композиції для місцевого застосування у ротовій порожнині, що містять флурбіпрофен і декспантенол | |
| MX2021014425A (es) | Composicion para el cuidado bucal. | |
| MY191247A (en) | Oral composition | |
| MX2019005495A (es) | Composicion para el cuidado bucal. | |
| ZA202101942B (en) | Oral care compositions comprising n-alkyl-n-acylglucamines | |
| MX2022006903A (es) | Productos orales con irritacion reducida. |